Authors:
TURECKI G
GROF P
CAVAZZONI P
DUFFY A
GROF E
AHRENS B
BERGHOFER A
MULLEROERLINGHAUSEN B
DVORAKOVA M
LIBIGEROVA E
VOJTECHOVSKY M
ZVOLSKY P
JOOBER R
NILSSON A
PROCHAZKA H
LICHT RW
RASMUSSEN NA
SCHOU M
VESTERGAARD P
HOLZINGER A
SCHUMANN C
THAU K
ROULEAU GA
ALDA M
Citation: G. Turecki et al., EVIDENCE FOR A ROLE OF PHOSPHOLIPASE C-GAMMA-1 IN THE PATHOGENESIS OFBIPOLAR DISORDER, Molecular psychiatry, 3(6), 1998, pp. 534-538
Authors:
OLESEN OV
LICHT RW
THOMSEN E
BRUUN T
VIFTRUP JE
LINNET K
Citation: Ov. Olesen et al., SERUM CONCENTRATIONS AND SIDE-EFFECTS IN PSYCHIATRIC-PATIENTS DURING RISPERIDONE THERAPY, Therapeutic drug monitoring, 20(4), 1998, pp. 380-384
Authors:
TURECKI G
ALDA M
GROF P
JOOBER R
CAVAZZONI P
DUFFY A
GROF E
AHRENS B
BERGHOFER A
MULLEROERLINGHAUSEN B
DVORAKOVA M
LIBIGEROVA E
VOJTECHOVSKY M
ZVOLSKY P
NILSSON A
PROCHAZKA H
LICHT RW
RASMUSSEN NA
SCHOU M
VESTERGAARD P
HOLZINGER A
SCHUMANN C
THAU K
ROULEAU GA
Citation: G. Turecki et al., NO EVIDENCE OF PROTEINS CONTAINING LONG POLYGLUTAMINE TRACTS IN THE PATHOGENESIS OF BIPOLAR DISORDER, American journal of medical genetics, 81(6), 1998, pp. 542-543
Authors:
VESTERGAARD P
LICHT RW
BRODERSEN A
RASMUSSEN NA
CHRISTENSEN H
ARNGRIM T
GRONVALL B
KRISTENSEN E
POULSTRUP I
Citation: P. Vestergaard et al., OUTCOME OF LITHIUM PROPHYLAXIS - A PROSPECTIVE FOLLOW-UP OF AFFECTIVE-DISORDER PATIENTS ASSIGNED TO HIGH AND LOW SERUM LITHIUM LEVELS, Acta psychiatrica Scandinavica, 98(4), 1998, pp. 310-315
Citation: Rw. Licht et al., THE EFFECT OF CHRONIC LITHIUM TREATMENT ON THE CALIBER OF AXONS AND NERVE-FIBERS IN THE RAT SURAL NERVE, European neuropsychopharmacology, 7(2), 1997, pp. 95-98
Authors:
TURECKI G
ALDA M
JOOBER R
LAFRENIERE RG
GROF P
AHRENS B
BERGHOFER A
CAVAZZONI P
DUFFY A
DVORAKOVA M
GROF E
HOLZINGER A
LIBIGEROVA E
LICHT RW
MULLEROERLINGHAUSEN B
NILSSON A
PROCHAZKA H
RASMUSSEN NA
SCHOU M
SCHUMANN C
THAU K
VESTERGAARD P
VOJTECHOVSKY M
ZVOLSKY P
ROULEAU GA
Citation: G. Turecki et al., INVESTIGATION OF GENES CONTAINING EXPRESSED CAG REPEATS IN BIPOLAR DISORDER, American journal of medical genetics, 74(6), 1997, pp. 611-611
Authors:
ALDA M
TURECKI G
GROF P
CAVAZZONI P
AHRENS B
BERGHOFER A
DUFFY A
DVORAKOVA M
GROF E
HOLZINGER A
JOOBER R
LIBIGEROVA E
LICHT RW
MARTIN RB
MULLEROERLINGHAUSEN B
NILSSON A
PROCHAZKA H
RASMUSSEN NA
SCHOU M
SCHUMANN C
THAU K
VESTERGAARD P
VOJTECHOVSKY M
ZVOLSKY P
ROULEAU GA
Citation: M. Alda et al., MOLECULAR-GENETIC INVESTIGATIONS OF SELECTED CANDIDATE LOCI IN LITHIUM-RESPONSIVE BIPOLAR DISORDER - COLLABORATIVE IGSLI STUDY, American journal of medical genetics, 74(6), 1997, pp. 641-641
Citation: Rw. Licht et J. Jensen, VALIDATION OF THE BECH-RAFAELSEN-MANIA-SCALE USING LATENT STRUCTURE-ANALYSIS, Acta psychiatrica Scandinavica, 96(5), 1997, pp. 367-372
Citation: Ov. Olesen et Rw. Licht, A NATURALISTIC STUDY OF CLOZAPINE SERUM CONCENTRATIONS IN PSYCHIATRIC-PATIENTS, Nordic journal of psychiatry, 50(5), 1996, pp. 413-418
Authors:
GOULIAEV G
LICHT RW
VESTERGAARD P
MERINDER L
LUND H
BJERRE L
Citation: G. Gouliaev et al., TREATMENT OF MANIC EPISODES - ZUCLOPENTHIXOL AND CLONAZEPAM VERSUS LITHIUM AND CLONAZEPAM, Acta psychiatrica Scandinavica, 93(2), 1996, pp. 119-124
Citation: Rw. Licht, THE RECRUITMENT PROCESS FOR A CONTROLLED-STUDY ON ANTIMANIC TREATMENT- METHODOLOGICAL ISSUES, Psychopharmacology, 118(2), 1995, pp. 7-7
Citation: Rw. Licht et al., EFFECT OF CHRONIC LITHIUM TREATMENT WITH OR WITHOUT HALOPERIDOL ON NUMBER AND SIZES OF NEURONS IN RAT NEOCORTEX, Psychopharmacology, 115(3), 1994, pp. 371-374
Citation: Rw. Licht et al., INTERINDIVIDUAL VARIATION IN SERUM ZUCLOPENTHIXOL AND PERPHENAZINE CONCENTRATIONS IN ORALLY TREATED PATIENTS, Nordic journal of psychiatry, 48(3), 1994, pp. 173-175
Authors:
LICHT RW
GOULIAEV G
VESTERGAARD P
DYBBRO J
LUND H
MERINDER L
Citation: Rw. Licht et al., TREATMENT OF MANIC EPISODES IN SCANDINAVIA - THE USE OF NEUROLEPTIC DRUGS IN A CLINICAL ROUTINE SETTING, Journal of affective disorders, 32(3), 1994, pp. 179-185